Sweden’s immune-oncology firm Alligator Bioscience today announced the successful completion of the manufacture of the first GMP drug product batch of its lead asset mitazalimab using a new improved ...

Research and Development (R&D) Expenses: R&D expenses decreased to $5.8 million for the three months ended March 31, 2025, ...

Costco's Stuart store opened to great public reception. However, there's still more Costco-related news coming for Martin and ...

Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...

Medadvisor shares today soared up to 60% after the company said it had found a tentative buyer for its Australian pharmacy business ...

The 24-week topline results from the Phase 2 VERONA study in DME were accepted for presentation at the Retina World Congress in May 2025, which will highlight DURAVYU's potential to transform the ...

Q1 2025 Earnings Call Transcript May 7, 2025 EyePoint Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.65 EPS, expectations were $-0.65. Operator: Good morning. My ...

Fifth-grade DARE program students celebrate at a graduation ceremony at Fort Fairfield Elementary School on April 30. In back ...

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

Durham, in his letter to the parole ... the crime than his alleged rehabilitation, Durham wrote. “The purportedly mitigating claims of the mere passage of time, completion of prison programs ...

Entered into an agreement to be acquired by Novartis for $7.00 per share in cash, with potential to receive an additional $7.00 per share in cash through a contingent ...

Cumberland Pharmaceuticals, Inc. ( NASDAQ: CPIX) Q1 2025 Earnings Conference Call May 6, 2024 4:30 PM ET Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - CEO Todd Anthony - VP, ...